Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 33, 2004 - Issue 4
72
Views
11
CrossRef citations to date
0
Altmetric
Original

Fructose‐1,6‐Diphosphate Suppresses T‐Lymphocyte Proliferation, Promotes Apoptosis and Inhibits Interleukins‐1, 6, β‐Actin mRNAs, and Transcription Factors Expression

, , , & , M.D.
Pages 407-421 | Published online: 26 Aug 2009

References

  • Abmayr S., Workman J. L. DNA protein interactions. Protocols in Molecular Biology, F. M. Ausubel, R. Brent, R. E. Kingston, D. O. Moore, J. G. Seidman, J. A. Smith, K. Struhl, L. M. Albright, O. M. Coen, A. Vark. John Wiley & Sons, New York 1997; 12.1
  • Bonz A. W., Lengenfelder B., Jacobs M., Strotmann J., Held S., Ertl G., Voelker W. Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism. Am. Heart J. 2003; 145: 693–699, [PUBMED], [INFOTRIEVE]
  • Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding. Anal. Biochem. 1976; 72: 248–254, [PUBMED], [INFOTRIEVE]
  • Breuss J. M., Cejna M., Bergmeister H., Kadl A., Baumgartl G., Steurer S., Xu Z., Koshelnick Y., Lipp J., De Martin R., Losert U., Lammer J., Binder B. R. Activation of nuclear factor‐kappa B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model. Circulation 2002; 105: 633–638, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Cohly H. H., Stephens J. W., Angel M. F., Johnson J. C., Markov A. K. The role of fructose 1,6‐diphosphate in cell migration and proliferation in an in vitro xenograft model of vascular wound healing. In Vitro Cell Dev. Biol. 1999a; 35: 510–514, [CSA]
  • Cohly H. H.P., Stephens J. W., Angel M. F., Johnson J., Markov A. K. Role of fructose‐1,6‐diphosphate in cell migration and proliferation in an in vitro xenograft blood vessel model of vascular wound healing. In Vitro Cell Dev. Bio‐Anim. 1999b; 35: 510–514, [CSA]
  • Cohly H., Stephens J., Markov A., Angel M., Campbell W., Ndebele K., Jenkins J. Cell culture conditions affect LPS inducibility of the inflammatory mediators in J774A.1 murine macrophages. Immunol. Invest. 2001; 30: 1–15, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Danenberg H. D., Welt F. G., Walker M., III, Seifert P., Toegel G. S., Edelman E. R. Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation 2002; 105: 2917–2922, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11: 1475–1489, [PUBMED], [INFOTRIEVE]
  • Farias L. A., Smith E. E., Markov A. K. Prevention of ischemic‐hypoxic brain injury and death in rabbits with fructose‐1,6‐diphosphate. Stroke 1990; 21: 606–613, [PUBMED], [INFOTRIEVE]
  • Fultz M. E., Wright G. L. Myosin remodeling in the contracting A7r5 smooth muscle cell. Acta Physiol. Scand. 2003; 177: 197–205, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Hardin C. D., Roberts T. M. Metabolism of exogenously applied fructose 1,6‐bisphosphate in hypoxic vascular smooth muscle. Am. J. Physiol. 1994; 267: H2325–H2332, [PUBMED], [INFOTRIEVE]
  • Hassinen I. E., Nuutinen E. M., Ito K., Nioka S., Lazzarino G., Giardina B., Chance B. Mechanism of the effect of exogenous fructose‐1,6‐bisphosphate on myocardial energy metabolism. Circulation 1991; 83: 584–593, [PUBMED], [INFOTRIEVE]
  • Hojo Y., Ikeda U., Katsuki T., Mizuno O., Fukazawa H., Kurosaki K., Fujikawa H., Shimada K. Interleukin expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 2000; 84: 83–87, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Jenkins J. K., Suwannaroj S., Elbourne K. B., Ndebele K., McMurray R. W. 17‐β estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of bcl‐2 and cyclin A. Int. Immunopharmacol. 2001; 1: 1867–1911, [CROSSREF]
  • Johnson D. E., Gao S. Z., Schroeder J. S., DeCampli W. M., Billingham M. E. The spectrum of coronary artery pathologic findings in human cardiac allografts. J. Heart Transplant. 1989; 8: 349–359, [PUBMED], [INFOTRIEVE]
  • Kermode H., Chan W. M., Williams A. J., Sitsapesan R. Glycolytic pathway intermediates activate cardiac ryanodine receptors. FEBS Lett. 1998; 431: 59–62, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Kirtley M. E., McKay M. Fructose‐1,6‐diphosphate, a regulator of metabolism. Mol. Cell. Biochem. 1977; 18: 141–149, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Marangos P. J., Fox A. W., Rriedel B. J., Royston D., Dziewanowska Z. E. Potential therapeutic applications of fructose‐1,6‐diphosphate. Exp. Opin. Invest. Drugs 1998; 7: 615–623
  • Marchionni N., Conti A., De Alfieri W., Di Bari M., Ferrucci L., Lombardi A., Moschi G., Pini R., Vannucci A. Hemodynamic and electrocardiographic effects of fructose‐1,6‐diphosphate in acute myocardial infarction. Am. J. Cardiol. 1985; 56: 266–269, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Markov A. K. Hemodynamic and metabolic effects of fructose‐1,6‐diphosphate in ischemia and shock. Experimental and clinical observations. Ann. Emerg. Med. 1986; 15: 1470–1477, [PUBMED], [INFOTRIEVE]
  • Markov A. K., Oglethorpe N. C., Blake T. M., Lehan P. H., Hellems H. K. Hemodynamic, electrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia. Am. Heart J. 1980; 100: 639–646, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Markov A. K., Neely W. A., Didlake R. H., Terry J., III, Causey A., Lehan P. H. Metabolic responses to fructose‐1,6‐diphosphate in healthy subjects. Metabolism 2000; 49: 698–703, [PUBMED], [INFOTRIEVE], [CSA]
  • Markov A. K., Rayburn T. S., Talton D. S., Netherland D. E., Moore C., Heath B., Cohly H. H. Fructose‐1,6‐diphosphate alone and in combination with cyclosporine potentiates rat cardiac allograft survival and inhibits lymphocyte proliferation and interleukin‐2 expression. Transplantation 2002a; 74: 1651–1654, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Markov A. K., Causey A. L., Didlake R. H., Lemos L. B. Prevention of alpha‐naphthylthiourea‐induced pulmonary edema with fructose‐1,6‐diphosphate. Exp. Lung Res. 2002b; 28: 285–299, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • McMurray R. W., Ndebele K., Hardy K. J., Jenkins J. K. 17‐∃ estradiol suppresses IL‐2 and IL‐2 receptor. Cytokine 2001; 14: 324–333, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Nicoletti I., Migliorati G., Pagliacci M. C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991; 139: 271–279, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • North A. J., Gimona M., Lando Z., Small J. V. Actin isoform compartments in chicken gizzard smooth muscle cells. J. Cell Sci. 1994; 107: 445–455, [PUBMED], [INFOTRIEVE]
  • Paul L. C., Fellstrom B. Chronic vascular rejection of the heart and the kidney: have rational treatment options emerged?. Transplantation 1992; 53: 1169–1179, [PUBMED], [INFOTRIEVE], [CSA]
  • Rus H. G., Vlaicu R., Niculescu F. Interleukin‐6 and interleukin‐8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996; 127: 227–263, [CROSSREF]
  • Russell M. E., Fujita M., Masek M. A., Rowan R. A., Billingham M. E. Cardiac graft vascular disease. Nonselective involvement of large and small vessels. Transplantation 1993; 56: 1599–1601, [PUBMED], [INFOTRIEVE], [CSA]
  • Schedlich L., Hill M., Lockett T. Antisense inhibition of beta‐actin mRNA localization and its effect on smooth muscle cell migration. Biol. Cell 1997; 89: 113–122, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Schevzov G., Lloyd C., Gunning P. J. High level expression of transfected beta‐and gamma‐actin genes differentially impacts on myoblast cytoarchitecture. Cell Biol. 1992; 117: 775–785, [CROSSREF]
  • Schulte H. M., Bamberger C. M., Elsen H., Herrmann G., Bamberger A. M., Barth J. Systemic interleukin‐1 alpha and interleukin‐2 secretion in response to acute stress and to corticotropin‐releasing hormone in humans. Eur. J. Clin. Invest. 1994; 24: 773–777, [PUBMED], [INFOTRIEVE], [CSA]
  • Steel R. G.D., Torrie J. H. Analysis of variance 1: the one way classification. Principles and Procedures of Statistics, R. G.D. Steel, J. H. Torrie. McGraw‐Hill Book Company, New York 1960; 111–112
  • Sun J. X., Farias L. A., Markov A. K. Fructose‐1,6‐diphosphate prevents intestinal ischemic reperfusion injury and death in rats. Gastroenterology 1990; 98: 117–126, [PUBMED], [INFOTRIEVE]
  • Tamaki T., Nakai T., Yamaue H. Fructose‐1,6‐biphosphate inhibits excess activation of Kupffer cell function induced by endotoxin. Dig. Dis. Sci. 2002; 47: 2179–2185, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Tullius S., Tilney N. L. Both alloantigen‐dependent and independent factors influence chronic rejection. Transplantation 1995; 59: 313–318, [PUBMED], [INFOTRIEVE], [CSA]
  • Yamasaki K., Asai T., Shimizu M., Aoki M., Hashiya N., Sakonjo H., Makino H., Kaneda Y., Ogihara T., Morishita R. Inhibition of NF‐kappa B activation using cis‐element ‘decoy’ of NF‐kappa B binding site reduces neointimal formation in porcine balloon‐injured coronary artery model. Gen. Ther. 2003; 10: 356–364, [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.